Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.710
-0.140 (-4.91%)
At close: Jul 11, 2025, 4:00 PM
2.720
+0.010 (0.37%)
After-hours: Jul 11, 2025, 4:37 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $52.81 million as of July 11, 2025. Its market cap has decreased by -22.38% in one year.
Market Cap
52.81M
Enterprise Value
33.30M
1-Year Change
-22.38%
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $52.81M, a decrease of -15.52%. That is a compound annual growth rate of -3.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 55.54M | -19.98% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |